Market capitalization | $9.51b |
Enterprise Value | $10.21b |
P/E (TTM) P/E ratio | 121.96 |
EV/FCF (TTM) EV/FCF | 54.44 |
EV/Sales (TTM) EV/Sales | 5.00 |
P/S ratio (TTM) P/S ratio | 4.66 |
P/B ratio (TTM) P/B ratio | 6.50 |
Revenue growth (TTM) Revenue growth | -3.48% |
Revenue (TTM) Revenue | $2.04b |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
11 Analysts have issued a Masimo Corporation forecast:
11 Analysts have issued a Masimo Corporation forecast:
Sep '24 |
+/-
%
|
||
Revenue | 2,043 2,043 |
3%
3%
|
|
Gross Profit | 1,022 1,022 |
3%
3%
|
|
EBITDA | 256 256 |
22%
22%
|
EBIT (Operating Income) EBIT | 161 161 |
7%
7%
|
Net Profit | 79 79 |
11%
11%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
Head office | United States |
CEO | Michelle Brennan |
Employees | 9,000 |
Founded | 1989 |
Website | www.masimo.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.